Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover

AUTOR(ES)

Ogata, Naoshi

FONTE

American Society for Clinical Investigation

RESUMO

Insulin receptor substrates (IRS-1 and -2) are essential for intracellular signaling by insulin and IGF-I, anabolic regulators of bone metabolism. Mice lacking the IRS-1 gene IRS-1–/– showed severe osteopenia with low bone turnover. IRS-1 was expressed in osteoblasts, but not in osteoclasts, of wild-type (WT) mice. IRS-1–/– osteoblasts treated with insulin or IGF-I failed to induce tyrosine phosphorylation of cellular proteins, and they showed reduced proliferation and differentiation. Osteoclastogenesis in the coculture of hemopoietic cells and osteoblasts depended on IRS-1 expression in osteoblasts and could not be rescued by IRS-1 expression in hemopoietic cells in the presence of not only IGF-I but also 1,25(OH)2D3. In addition, osteoclast differentiation factor (RANKL/ODF) was not induced by these factors in IRS-1–/– osteoblasts. We conclude that IRS-1 deficiency in osteoblasts impairs osteoblast proliferation, differentiation, and support of osteoclastogenesis, resulting in low-turnover osteopenia. Osteoblastic IRS-1 is essential for maintaining bone turnover, because it mediates signaling by IGF-I and insulin and, we propose, also by other factors, such as 1,25(OH)2D3.

Documentos Relacionados

• Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation
• Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
• Biphasic modulation of insulin receptor substrate-1 during goitrogenesis
• Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.
• Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus.